Format

Send to

Choose Destination
Int J Radiat Oncol Biol Phys. 2018 Nov 15;102(4):775-782. doi: 10.1016/j.ijrobp.2018.08.039. Epub 2018 Oct 18.

The Importance of Imaging in Radiation Oncology for National Clinical Trials Network Protocols.

Author information

1
Imaging and Radiation Oncology Core QA Center Rhode Island, University of Massachusetts Medical School, Lincoln, Rhode Island. Electronic address: TJFitzgerald@qarc.org.
2
Imaging and Radiation Oncology Core QA Center Rhode Island, University of Massachusetts Medical School, Lincoln, Rhode Island.
3
Imaging and Radiation Oncology Core RT QA Center Philadelphia, American College of Radiology Center for Research, Philadelphia, Pennsylvania.
4
Alliance for Clinical Trials in Oncology, State University of New York Upstate Medical University, Syracuse, New York.
5
Children's Oncology Group, Northwestern Medicine, Chicago, Illinois.
6
ECOG-ACRIN Cancer Research Group, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.
7
SWOG, Department of Radiation Oncology, University of Florida College of Medicine, Gainesville, Florida.
8
Department of Radiation Oncology, Rutgers-Robert Wood Johnson Medical School, New Jersey Medical School and Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey.
9
Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri.
10
Imaging and Radiation Oncology Core QA Center Houston, MD Anderson Cancer Center, Houston, Texas.
11
Imaging and Radiation Oncology Core QA Center Ohio, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio.
12
SWOG and Alliance for Clinical Trials in Oncology, Herbert Irving Comprehensive Cancer Center, Columbia University Medical Center, New York, New York.

Abstract

Imaging is essential in successfully executing radiation therapy (RT) in oncology clinical trials. As technically sophisticated diagnostic imaging and RT were incorporated into trials, quality assurance in the National Clinical Trials Network groups entered a new era promoting image acquisition and review. Most trials involving RT require pre- and post-therapy imaging for target validation and outcome assessment. The increasing real-time (before and during therapy) imaging and RT object reviews are to ensure compliance with trial objectives. Objects easily transmit digitally for review from anywhere in the world. Physician interpretation of imaging and image application to RT treatment plans is essential for optimal trial execution. Imaging and RT data sets are used to credential RT sites to confirm investigator and institutional ability to meet trial target volume delineation and delivery requirements. Real-time imaging and RT object reviews can be performed multiple times during a trial to assess response to therapy and application of RT objects. This process has matured into an effective data management mechanism. When necessary, site and study investigators review objects together through web media technologies to ensure the patient is enrolled on the appropriate trial and the intended RT is planned and executed in a trial-compliant manner. Real-time imaging review makes sure: (1) the patient is entered and eligible for the trial, (2) the patient meets trial-specific adaptive therapy requirements, if applicable, and (3) the intended RT is according to trial guidelines. This review ensures the study population is uniform and the results are believable and can be applied to clinical practice.

PMID:
30353882
PMCID:
PMC6510266
[Available on 2019-11-15]
DOI:
10.1016/j.ijrobp.2018.08.039
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center